StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Total Debt / Adjusted TTM EBITDA by Quarter

Total Debt / Adjusted TTM EBITDA (×)

QuarterlyAnnual

Thermo Fisher Scientific Total Debt / Adjusted TTM EBITDA: 3.40× in Q3 2026, up 6.3% from a year earlier.

Latest, Q3 2026
3.40
Period ended Sep 30, 2026
Change on a year earlier
+6.3%
3.20 in Q3 2025
History
14 quarters
Since Q4 2021
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“Total debt / adjusted TTM EBITDA 3.2 X 2.9 X 3.5 X 3.8 X 3.6 X 3.4 X”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package (Page 12 Leverage Ratios).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Debt / Adjusted TTM EBITDA (×)Year on yearSource
Q3 2026Sep 30, 20263.40+6.3%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20263.60+12.5%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20263.80+18.7%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20253.50+20.7%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20253.20-3.0%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20253.20-3.0%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20253.20-3.0%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20242.90-9.4%Q3 2026 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20243.30–Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20243.30–Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 20243.30–Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20233.20+10.3%Q3 2026 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 20222.90+7.4%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2021Dec 31, 20212.70–Q4 & FY2024 Reconciliation of Financial Information ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Total Debt / Adjusted TTM EBITDA (×), quarterly Q4 2021–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/lev-total-debt-adj-ebitda-x

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.